“showed a trend”

Spliced variant of fibronectin, extra domain A ( ED-A ), showed a trend towards higher mRNA expression in the mucosa of IFX failure patients compared to IFX naïve patients (p = 0.08).

Patients with a high RDI were significantly older ( p = 0.01) and showed a trend towards a higher body mass index ( p = 0.08) than patients with a normal RDI but had no other risk factors for OSAS.

One RCT showed a trend toward a decreased risk of low birth weight infants (6.6% GPC vs 12.5% control; p = 0.08; [ 32 ] while another showed no difference except in the subgroup that attended at least half of GPC visits (5.2% GPC vs 10.7% Control; p < 0.05; [ 8 ]).

Finally, in the IP site, microencapsulated islets showed a trend toward decreased survival when compared with transplants in the EFP site (MST, undefined; P = 0.08) (Figure 2 C).

These TPJ-dmPFC connectivity beta weights differed significantly between the disgust and neutral conditions in the left hemisphere (t 18 = 3.54, p = 0.002), and showed a trend to significance in the right (t 18 = 1.82, p = 0.08) (Fig. 6B,C ).

FSHD2 patients showed a trend to express more ACVRIIB than FSHD1 (+120%, p = 0.08).

A particular subset of CD8 + cells, the CD8 + CD103 + T cells, also known as tumor-resident memory T cells (TRM), showed a trend for higher infiltration in Rs (median: 1.1 vs 0.0 cell/mm 2 , p=0.08; figure 1B ).

Also, APOBEC3B mRNA levels measured in distant metastases ( N = 35) showed a trend towards higher expression when compared to regional lymph node metastases ( N = 20) of unmatched cases (Mann-Whitney U test P = 0.08, Fig 2A ).

Although calprotectin showed a trend ( p = 0.08), EULAR responders at 6 months did not have significantly higher values of any of the markers at baseline.

ChAdOx1 using lpCMV elicited the most potent cellular responses (mean ≈5000 SFC/10 6 PBMCs), significantly higher than those elicited by cSE4 ( p < 0.005) and showed a trend toward greater magnitude than cSE5 ( p = 0.08).

Between groups analysis at the end of 6 th month using Mann-Whitney U-test (as sample in two groups was <30) showed a trend toward lower FBS in completers as compared to dropouts (completers – mean [SD]: 165.88 (42.77); dropouts: 222.73 (89.32); U = 86.0; P = 0.08).

Patients with mutated MEN1 and DAXX/ATRX pathways showed a trend toward better survival, compared to patients with the wild-type genes (p = 0.08 and 0.12, respectively).

However, only FASN expression was significantly elevated (One-way mixed ANOVA, P = 0.043), while SCD1 showed a trend towards increased expression (One-way mixed ANOVA, P = 0.08), and ACC expression change was insignificant (One-way mixed ANOVA, P = 0.188; Fig. 7 ).

Pooling data from combined PB and WP treatments showed a trend for greater change in LBM from baseline to 12 wk compared with MDP treatment (0.69 kg; 95% CI: −0.08, 1.46 kg; P = 0.08).

Good cognitive performers also showed a trend of a faster decline in the bilateral ACC functional connectivity as compared to poor cognitive performers ( p = 0.08).

Point by point comparisons between groups showed a trend in lower values for OB compared to CT at 0700h, 0900h and 1900h (p = 0.08).

Both edoxaban doses demonstrated noninferiority to VKA in reducing the risk of stroke or SE in the primary analysis, including patients in the intent-to-treat population who received study drug during the treatment period (annual rates of 1.61%, 1.18%, and 1.50% for low-dose edoxaban, high-dose edoxaban, and warfarin, respectively); high-dose edoxaban showed a trend toward better efficacy vs warfarin in a prespecified superiority analysis of the intent-to-treat population during the entire study period (1.57% vs 1.80%; P =0.08). 29 In Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), 18,201 patients (mean CHADS 2 score 2.1; median age 70 years) were randomized to apixaban 5 mg twice daily (2.5 mg doses were used in patients with two or more of the following: age ≥80 years, body weight ≤60 kg, or serum creatinine level ≥1.5 mg/dL) or warfarin.

Interestingly, 5-aza-dC treatment upregulated Ramp1 expression and showed a trend toward downregulation of Calca ( p = 0.08), although this did not reach statistical significance (Fig. 6 C + D).

Vaccination with Nα-syn was the only strategy that showed a trend to induce RORγt protein as compare to naive ( p = 0.08, Fisher’s LSD).

Responders showed a trend towards having higher overall ε long ( p = 0.08).

While a model including all set size 16 trials did not yield a significant effect of stimulus type, we found that the reduced response to the distractors (indicated by a negative T -value for the contrast between β D and β U over the occipital sensors) showed a trend effect with p = 0.08 for the cluster.

Incompatible amplitudes showed a trend-significant group effect [ F (2, 91) = 2.5, p = 0.08, η p 2 = 0 . 05 ], with a significant effect of RACC and RT.

However, there were interactions that showed a trend for significance (p=0.08) ( Table 3 ).

Animals treated with RGB+KA also had steady GluR1 levels at this time; however, the ventral granule cell layer (VGCL) showed a trend of decline at 87.9 ± 7.2% of the control ( p =0.08).

The SUVmax showed a trend for predicting the outcome (p= 0.08; OR 2.6), ( Table 2 ).